We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBLL
2551
CeriBell Inc
CBLL
$639M
| $1.01M | ﹤0.01% |
54,874
+311
| +0.6% | +$6.25K |
|
2552
Manitowoc
MTW
$510M
| $1M | ﹤0.01% |
86,110
+445
| +0.5% | +$5.97K |
|
2553
Fulcrum Therapeutics
FULC
$251M
| $994K | ﹤0.01% |
129,618
+17,415
| +16% | +$162K |
|
|
DHIL
2554
DELISTED
Diamond Hill
DHIL
| $988K | ﹤0.01% |
5,740
-362
| -6% | -$62K |
|
2555
Custom Truck One Source
CTOS
$2.47B
| $985K | ﹤0.01% |
149,991
+960
| +0.6% | +$6.3K |
|
2556
Greenlight Captial
GLRE
$559M
| $982K | ﹤0.01% |
56,797
+430
| +0.8% | +$6.26K |
|
2557
Pulse Biosciences
PLSE
$2.09B
| $981K | ﹤0.01% |
45,435
-2,750
| -6% | -$50.8K |
|
2558
OmniAb
OABI
$304M
| $979K | ﹤0.01% |
623,876
-250,636
| -29% | -$452K |
|
2559
Red River Bancshares
RRBI
$654M
| $972K | ﹤0.01% |
10,742
+78
| +0.7% | +$6.6K |
|
|
COSO
2560
CoastalSouth Bancshares
COSO
$325M
| $970K | ﹤0.01% |
39,464
+30,220
| +327% | +$733K |
|
2561
SandRidge Energy
SD
$516M
| $970K | ﹤0.01% |
59,484
-50,654
| -46% | -$821K |
|
2562
Bit Digital
BTBT
$502M
| $970K | ﹤0.01% |
740,240
-133,374
| -15% | -$245K |
|
|
BFS
2563
Saul Centers
BFS
$875M
| $969K | ﹤0.01% |
29,744
+167
| +0.6% | +$5.53K |
|
2564
Opko Health
OPK
$921M
| $966K | ﹤0.01% |
846,993
+5,157
| +0.6% | +$6.35K |
|
2565
Delcath Systems
DCTH
$424M
| $963K | ﹤0.01% |
103,774
+37,416
| +56% | +$362K |
|
2566
Prime Medicine
PRME
$538M
| $960K | ﹤0.01% |
275,931
+24,295
| +10% | +$92.5K |
|
|
NUTX
2567
Nutex Health
NUTX
$1.05B
| $960K | ﹤0.01% |
10,098
+2,030
| +25% | +$249K |
|
2568
Hackett Group
HCKT
$246M
| $959K | ﹤0.01% |
73,678
+640
| +0.9% | +$10.2K |
|
|
CCRN
2569
DELISTED
Cross Country Healthcare
CCRN
| $958K | ﹤0.01% |
101,949
+24,727
| +32% | +$221K |
|
2570
Movado Group
MOV
$818M
| $956K | ﹤0.01% |
39,154
+197
| +0.5% | +$4.66K |
|
2571
Byrna Technologies
BYRN
$83.7M
| $956K | ﹤0.01% |
104,139
+48,052
| +86% | +$630K |
|
|
SION
2572
Sionna Therapeutics
SION
$2.06B
| $951K | ﹤0.01% |
23,734
| – | – |
|
|
XRN
2573
Chiron Real Estate Inc
XRN
$540M
| $947K | ﹤0.01% |
28,638
+188
| +0.7% | +$6.61K |
|
2574
Mistras Group
MG
$494M
| $944K | ﹤0.01% |
63,884
-4,052
| -6% | -$58.5K |
|
2575
Dine Brands
DIN
$435M
| $943K | ﹤0.01% |
35,926
+233
| +0.7% | +$7.57K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.